Confluence Wealth Services Inc. Invests $1.55 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Confluence Wealth Services Inc. purchased a new position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 3,077 shares of the healthcare conglomerate’s stock, valued at approximately $1,545,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Prosperity Consulting Group LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $738,000. Pittenger & Anderson Inc. increased its holdings in shares of UnitedHealth Group by 6.3% in the fourth quarter. Pittenger & Anderson Inc. now owns 34,292 shares of the healthcare conglomerate’s stock worth $17,219,000 after purchasing an additional 2,037 shares during the last quarter. Cape Cod Five Cents Savings Bank increased its holdings in shares of UnitedHealth Group by 0.8% in the fourth quarter. Cape Cod Five Cents Savings Bank now owns 16,241 shares of the healthcare conglomerate’s stock worth $8,155,000 after purchasing an additional 127 shares during the last quarter. CFO4Life Group LLC grew its position in UnitedHealth Group by 18.6% in the fourth quarter. CFO4Life Group LLC now owns 3,564 shares of the healthcare conglomerate’s stock worth $1,790,000 after acquiring an additional 558 shares in the last quarter. Finally, Pinebridge Investments L.P. grew its position in UnitedHealth Group by 92.6% in the fourth quarter. Pinebridge Investments L.P. now owns 168,353 shares of the healthcare conglomerate’s stock worth $84,537,000 after acquiring an additional 80,939 shares in the last quarter. Institutional investors and hedge funds own 87.48% of the company’s stock.

NYSE:UNH traded down $7.35 during mid-day trading on Thursday, hitting $478.80. The company’s stock had a trading volume of 3,996,719 shares, compared to its average volume of 3,376,028. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.78 and a quick ratio of 0.79. The stock has a market cap of $449.20 billion, a price-to-earnings ratio of 26.21, a PEG ratio of 1.56 and a beta of 0.83. The business’s fifty day moving average is $511.14 and its two-hundred day moving average is $484.25.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.38 by $0.11. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The business had revenue of $80.15 billion for the quarter, compared to analyst estimates of $78.77 billion. During the same period in the prior year, the company posted $5.31 EPS. The company’s revenue for the quarter was up 14.2% on a year-over-year basis. Analysts anticipate that UnitedHealth Group Incorporated will post 21.75 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 22nd. Shareholders of record on Monday, March 14th were issued a $1.45 dividend. This represents a $5.80 annualized dividend and a dividend yield of 1.21%. The ex-dividend date of this dividend was Friday, March 11th. UnitedHealth Group’s payout ratio is 31.75%.

Several research analysts recently commented on the company. Oppenheimer lifted their price target on UnitedHealth Group from $550.00 to $600.00 and gave the stock an “outperform” rating in a research report on Monday, April 18th. Barclays lifted their price target on shares of UnitedHealth Group from $495.00 to $565.00 and gave the company an “overweight” rating in a research note on Wednesday, March 30th. Credit Suisse Group boosted their price objective on shares of UnitedHealth Group from $564.00 to $595.00 and gave the stock an “outperform” rating in a research note on Monday, April 18th. StockNews.com started coverage on shares of UnitedHealth Group in a research note on Thursday, March 31st. They issued a “strong-buy” rating for the company. Finally, Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $570.00 to $577.00 and gave the stock an “overweight” rating in a research note on Monday, April 18th. Two research analysts have rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $550.17.

In other UnitedHealth Group news, Director Paul R. Garcia purchased 2,146 shares of the business’s stock in a transaction that occurred on Tuesday, February 22nd. The stock was acquired at an average cost of $464.97 per share, with a total value of $997,825.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 6,000 shares of the business’s stock in a transaction dated Friday, February 25th. The stock was sold at an average price of $470.38, for a total value of $2,822,280.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 18,000 shares of company stock worth $8,776,840. Insiders own 0.55% of the company’s stock.

About UnitedHealth Group (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.